Prescient

We’re a global team of bioscience specialists providing integrated, competitive and customer insights driven strategic consultancy across the full drug lifecycle. We build from a foundation of deep science and clinical-based insights. But while science and strategy may underpin our business, what drives it are deep, collaborative relationships. True partnerships. A true partnership involves going further and digging deeper in search of transformational insights, diverse perspectives and industry-challenging ideas – and applying them with real value. This blend of deep relationships, strategic rigour and scientific expertise unlocks the full potential of healthcare innovation. Innovation with the power to significantly improve people’s lives around the world. Prescient has been a portfolio company of Bridgepoint Development Capital since 2021 and Baird Capital since 2017. For more information, please visit: www.prescienthg.com.